These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. In vivo observations of chlorpromazine ocular deposits in a patient on long-term chlorpromazine therapy. Razeghinejad MR; Nowroozzadeh MH; Zamani M; Amini N Clin Exp Ophthalmol; 2008 Aug; 36(6):560-3. PubMed ID: 18954320 [TBL] [Abstract][Full Text] [Related]
24. Phototoxic corneal and lens opacities in dogs receiving a fungicide, 2,6-dichloro-4-nitroaniline. Bernstein HN; Curtis J; Earl FL; Kuwabara T Arch Ophthalmol; 1970 Mar; 83(3):336-48. PubMed ID: 5415852 [No Abstract] [Full Text] [Related]
25. Chlorpromazine dose for people with schizophrenia. de Haan S; Liu X Schizophr Bull; 2009 May; 35(3):491-2. PubMed ID: 19342426 [No Abstract] [Full Text] [Related]
26. SKIN PIGMENTATION AND CORNEAL AND LENS OPACITIES WITH PROLONGED CHLORPROMAZINE THERAPY. GREINER AC; BERRY K Can Med Assoc J; 1964 Mar; 90(11):663-5. PubMed ID: 14127375 [TBL] [Abstract][Full Text] [Related]
28. LENTICULAR AND CORNEAL OPACITIES DURING PHENOTHIAZINE THERAPY. BARSA JA; NEWTON JC; SAUNDERS JC JAMA; 1965 Jul; 193():10-2. PubMed ID: 14297702 [No Abstract] [Full Text] [Related]
29. Ocular changes and phenothiazine derivatives in long-term residents of a mental retardation center. Gowdey CW; Coleman LM; Crawford EM Psychiatr J Univ Ott; 1985 Dec; 10(4):248-53. PubMed ID: 2868472 [No Abstract] [Full Text] [Related]
30. Long term evolution of the side-effect lens opacities induced by chlorpromazine prolonged therapy. Baron JB; Rivoalan Y; Morel P Agressologie; 1971; 12(1):57-60. PubMed ID: 5088348 [No Abstract] [Full Text] [Related]
31. [Complications on the part of the eyes during employment of psychotropic drugs (review of the foreign literature)]. Gol'dovskaia IL Zh Nevropatol Psikhiatr Im S S Korsakova; 1969; 69(6):935-9. PubMed ID: 4905472 [No Abstract] [Full Text] [Related]
32. [An evaluation of single or multiple dosage of antipsychotic agents in the treatment of schizophrenia]. Jiang ZN Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1986 Feb; 19(1):41-3. PubMed ID: 3743245 [No Abstract] [Full Text] [Related]
33. The role of corneal exposure in cataract formation in DFP-treated guinea pigs. Bronson LJ; Lazar M Am J Ophthalmol; 1970 May; 69(5):858-60. PubMed ID: 5441357 [No Abstract] [Full Text] [Related]
34. SKIN PIGMENTATION, CORNEAL AND LENS OPACITIES WITH PROLONGED CHLORPROMAZINE TREATMENT. MASSEY LW Can Med Assoc J; 1965 Jan; 92(4):186-7. PubMed ID: 14232196 [No Abstract] [Full Text] [Related]
35. Toxic psychosis induced by high-dosage chlorpromazine therapy. Beszterczey A; Pecknold JC Can Med Assoc J; 1971 May; 104(10):884 passim. PubMed ID: 5574054 [No Abstract] [Full Text] [Related]
36. Lenticular deposits associated with chloroquine Keratopathy. Lal S; Gupta AK Indian J Ophthalmol; 1974 Jun; 22(2):34-5. PubMed ID: 4461692 [No Abstract] [Full Text] [Related]
37. Corneal opacities after cataract surgery with hypromellose. Newton JN; Roberts CJ; Canning C Lancet; 2000 Jan; 355(9200):290. PubMed ID: 10675083 [TBL] [Abstract][Full Text] [Related]